Drug recall · March 27, 2019
Etomidate Injection recall
Why: Subpotent Drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Etomidate Injection, USP 20 mg/10mL (2mg/mL) 10 mL Single-Dose Vial, Rx only, Manufactured for: Heritage Pharmaceuticals Inc. Made in India, NDC 23155-160-31
- Lots / codes
Lot #: AMA701, Exp. March 2019; AMA702, AMA703, Exp August 2019.
- Quantity
- 11888 units
- Company
- Heritage Pharmaceuticals, Inc., East Brunswick, NJ
- Distribution
- Nationwide within the United States
- Initiated
- February 15, 2019 · Voluntary: Firm initiated
- Classified
- March 27, 2019
- Reported
- March 27, 2019
- Ended
- March 4, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Etomidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.